Etiology and pathogenesis of multiple sclerosis

Seminars in Neurology

Volumn 18, Issue 3, 1998, Pages 287-294

  Sørensen, Torben L ^a,b   Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Multiple sclerosis; Pathogenesis

Indexed keywords

AUTOIMMUNE DISEASE; CLINICAL RESEARCH; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; INFLAMMATORY CELL; MULTIPLE SCLEROSIS; NERVE FIBER; OLIGODENDROGLIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE INJURY;

EID: 0031739621     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040879     Document Type: Review

References (86)

1. Oksenberg J, Seboun E, Hauser S. Genetics of demyelinating diseases. Brain Pathol 1996;6:289-289
2. Bell JI, Lathrop GM. Multiple loci for multiple sclerosis. Nat Genet 1996;13:377-378
3. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-476
4. Haines JL, TerMinassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996;13:469-471
5. Sawcer S, Jones HB, Feakes R, et al A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-468
6. Yaouanq J, Semana G, Eichenbaum S, et al. Evidence for linkage disequilibrium between HLADRB1 gene and multiple sclerosis. Science 1997;276:661
7. Seboun E, Robinson M, Doolittle T, et al. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell 1989;57:1095-1100
8. Utz U, Biddison W, McFarland H, et al. Skewed T cell receptor repertoire in genetically identical twins with multiple sclerosis correlates with disease. Nature 1993;364:243-247
9. Tienari P, Wikstrom J, Sajantila A, et al. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 1992;340:987-991
10. Sadovnick A, Ebers G. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993;20:17-29
11. Ebers GC, Sadovnick A, Risch N. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995;377:150-151
12. Sadovnick A, Ebers GC, Dyment D, et al. Evidence for genetic basis of multiple sclerosis. Lancet 1996;347:1728-1730
13. Sadovnick A, Armstrong H, Rice G, et al. A population-based study of multiple sclerosis in twins: Update. Ann Neurol 1993; 33:281-285
14. Ebers GC, Bulman D, Sadovnick A, et al. A population-based study of multiple sclerosis in twins. N Eng J Med 1986;315: 1638-1642
15. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin 1996;14:291-308
16. Hartung HP, Schafer B, van der Meide PH, et al. The role of interferon-γ in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990; 27:247-257
17. Kurtzke JF. MS from an epidemiological viewpoint. Lancaster: MTP Press LTD, 1977:83-83
18. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features. Ann Neurol 1979;5:6
19. Raine CS. Biology of disease. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab Invest 1984;50: 608-635
20. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin: Springer-Verlag, 1983
21. Baker D, O'Neill JK, Turk JL. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol 1991;134:505-510
22. Kennedy MK, Torrance DS, Picha KS, et al Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL10 mRNA expression correlates with recovery. J Immunol 1992;149:2496-2505
23. Wucherpfennig K, Strominger J. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-706
24. Scherer MT, Ignatowitz L, Winslow GM, et al. Superantigens: Bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993;9:101-128
25. Hickey W. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1991;1:97-105
26. Hartung HP, Schafer B, Heininger K, et al. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase. Ann Neurol 1988;60, 3:458
27. Heininger K, Schafer B, Hartung HP, et al. The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T cell line. Ann Neurol 1988;23:326-331
28. Brocke S, Gaur A, Piercy C, et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 1993;365:642-644
29. Hafler DA, Fallis RJ, Dawson DM, et al. Pilot study of antipan T cell monoclonal antibodies for the treatment of progressive multiple sclerosis. Neurology 1985;35:103-103
30. Hafler D, Fox DA, Manning ME, et al. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985;312:1405-1411
31. Allegretta M, Nicklas J, Sriram S, et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990;247:718-721
32. Allegretta M, Albertini R, Howell M, et al. Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J Clin Invest 1994
33. Hartung HP, Zielasek J, Toyka KV. Reactive nitrogen intermediates: Effector molecules of immunemediated inflammatory nervous system disorders [letter; comment]? Ann Neurol 1993;33:422
34. Hickey WF, Hsu BL, Kimura H. T lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-260
35. Dunon D, Pali L, Imhof BA. To stick or not to stick: The new leukocyte homing paradigm. Curr Opin Cell Biol 1996;8:714-718
36. Imhof BA, Dunon D. Leukocyte migration and adhesion. Adv Immun 1995;58:345-416
37. Springer T. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76: 301-314
38. Butcher E. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036
39. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-67
40. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995;11:549-599
41. DeGrendele H, Estess P, Siegelman M. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672-674
42. Hartung HP, Kieseier BC. Targets for the therapeutic action of interferonβ in multiple sclerosis [editorial]. Ann Neurol 1996;40:825-826
43. Hartung HP, Reiners K, Schmidt B, et al. Serum interleukin2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: Comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 1991;30:48-53
44. Paty D, Li D, Group U, et al. Interferon β1b is effective in relapsing-remitting multiple sclerosis. II. MRI results of a multicenter, randomized, doubleblind, placebo-controlled trial. Neurology 1993;43:662-667
45. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292
46. Bo L, Mork S, Kong P, et al. Detection of MHC class II-antigens on macrophages and microglia, but on astrocytes and endothelia in active MS. J Neuroimmunol 1994;51:135-146
47. Phillips MJ, Needham M, Weller RO. Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat. J Pathol 1997;182:457-464
48. Mosmann TR, Coffman RL, TH1 and TH2 cells. Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173
49. Rieckmann P, Albrecht M, Kitze B, et al. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995;37:82-88
50. Sharief M, Henteges R. Association between tumor necrosis factora and disease progression in chronic progressive multiple sclerosis. N Engl J Med 1991;325:467-472
51. Beck J, Rondot P, Catinot L, et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol Scand 1988;78:318-323
52. Imamura K, Suzumura A, Hayashi F, et al. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 1993;87:281-285
53. Hartung HP, Reiners K, Archelos JJ, et al. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-193
54. Williams K, Ulvestad E, Antel JP. B7/BB1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 1994;24:3031-3037
55. Dangond F, Windhagen A, Groves CJ, et al. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J Neuroimmunol 1997;76: 132-138
56. De SR, Giampaolo A, Giometto B, et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neurol Neurosurg Psychiatry 1995;54:175-187
57. Trinchieri G. Interleukin 12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-276
58. Pollard JD, Westland KW, Harvey GK, et al. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann Neurol 1995;37:467-475
59. Gourmala NG, Buttini M, Limonta S, et al. Differential and time-dependent expression of monocyte chemoattractant protein1 mRNA by astrocytes and macrophages in rat brain: Effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol 1997;74:35-44
60. Brosnan CF, Bornstein MB, Bloom BR. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 1981; 126:614-620
61. Stoll G, Schmidt B, Jander S, et al. Presence of the terminal complement complex (C5b9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991;30:147-155
62. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37: 424-435
63. Bo L, Peterson JW, Mork S, et al. Distribution of immunoglobulin superfamily members ICAM1, 2, 3 and the b2 integrin LFA1 in multiple sclerosis lesions. J Neurol Exp Neuropathol 1996; 55:1066-1072
64. Elices MJ, Tsai V, Strahl D, et al. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93: 405-416
65. Yednock T, Cannon C, Fritz L, et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against a 4b1 integrin. Nature 1992;356:63-66
66. Welsh C, Rose J, Hill K, et al. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA1a. J Neuroimmunol 1993;43:161-167
67. Rollins BJ. Chemokines. Blood 1997;90:909-928
68. Pan Y, Lloyd C, Zhou H, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997;387:611-617
69. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX(3)C motif. Nature 1997; 385: 640-644
70. Ransohoff R, Glabinski A, Tani M. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 1996;7:35-46
71. Tani M, Fuentes ME, Peterson JW, et al. Neutrophil infiltration, glial reaction and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest 1996;98:529-539
72. Karpus WJ, Lukacs NW, McRae BL, et al. An important role for the chemokine macrophage inflammatory protein1a in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 1995; 155:5003-5010
73. Karpus WJ, Lukacs NW, McRae BL, et al. Treatment of mice with antiMIP1 alpha prevents PLP peptide-induced experimental autoimmune encephalomyelitis [abstract]. FASEB J 1994;8:A199
74. Oksenberg J, Panzura M, Begovich A, et al. Selection for T cell receptor VDJ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362:68-70
75. Prineas JW. Pathology of the early lesions of multiple sclerosis. Hum Pathol 1975;6:531
76. Prineas JW, Graham JS. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown Ann Neurol 1981;10:149-158
77. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23: 339-346
78. Bo L, Dawson TM, Wesselingh S, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778-786
79. Linington C, Berger T, Perry L, et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 1993;23:1364-1372
80. Lucchinetti C, Bruck W, Rodriquez M, et al. Distinct pattern of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-259
81. Losseff NA, Wang L, Lang HM, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996; 119:2009-2019
82. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-391
83. Matthews PM, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996; 119:715-722
84. Ferguson B, Matyszak M, Esiri M, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399
85. Trapp B, Peterson J, Ransohoff R, et al. Axonal transection in multiple sclerosis lesions. N Engl J Med (in press)
86. Rudick R, Cohen J, Weinstock-Guttman B, et al. Management of multiple sclerosis. N Engl J Med 1997;337:1604-1612